Sickle cell disease: laboratory investigations and hemoglobin study.

Citation
H. Wajcman et R. Galacteros, Sickle cell disease: laboratory investigations and hemoglobin study., B S PATH EX, 94(2), 2001, pp. 80-84
Citations number
22
Categorie Soggetti
Envirnomentale Medicine & Public Health
Journal title
BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
ISSN journal
00379085 → ACNP
Volume
94
Issue
2
Year of publication
2001
Pages
80 - 84
Database
ISI
SICI code
0037-9085(200105)94:2<80:SCDLIA>2.0.ZU;2-N
Abstract
The diagnosis of any sickle cell disease syndrome is based on the unambiguo us identification of HbS, Electrophoretic tests are usually the first to be performed. A much better resolution is obtained with isoelectricfocusing t han with the more conventional cellulose acetate electrophoresis at alkalin e pH. In some laboratories the first test is cation exchange HPLC The diagn osis of HbS should never be accepted if not confirmed by a second test, mor e specific of this Hb such as the solubility test or electrophoresis on aga r in citrate buffer. The laboratory should also evaluate other factors interacting with HbS, suc h as HbF level, sickle cell restriction haplotype, association with alpha - thalassemias. It should also evaluate other cellular factors and, in case o f symptomatic heterozygous patients, help to understand of the underlying m echanisms.